NEW YORK (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying Mylan for $40 billion, saying it was a better deal than the smaller rival's offer to buy Perrigo Co.
The bid comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T
12:55 McDonald's shares pop as investors cheer third-quarter beat
11:10 Merged BAT-Reynolds could be loaded with up to $55 billion of debt, analysts say
23:06 AT&T discussed takeover in meetings with Time Warner: Bloomberg